Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
29 May, 2017 11:29 IST
Narayana Hrudayalaya to acquire 100% stake in NewRise Healthcare
Source: IRIS | 21 Apr, 2017, 03.13PM
Comments  |  Post Comment

Narayana Hrudayalaya (NH), a leading healthcare services provider in India, has entered into a definitive agreement to acquire 100% stake in NewRise Healthcare Private from Panacea Biotec to announce its first hospital in Gurugram.

This transaction is intended to consolidate NH's footprint in the Northern cluster and therefore serve the region's fast expanding healthcare space. With a flexible business model, NH aims to fast-track its penetration and emerge as a prominent healthcare services provider in the growing NCR market.

This multi-speciality hospital is in final stages of completion and is expected to be commissioned within the next 9 months. Located in South-Western part of NCR, it complements group's East Delhi based Dharamshila Narayana Superspeciality Hospital which is presently an oncology focused unit and will be upgraded to a multispeciality tertiary care unit. This will help create a strong regional network and drive operational synergies.

These recently consummated transactions by NH also emphasize the group's intention to create a meaningful Pan-India presence. These new initiatives will enable NH to replicate its established business model to newer regions while providing quality and affordable healthcare services.

Ashutosh Raghuvanshi, Vice Chairman, Managing Director and Group CEO, Narayana Hrudayalaya, said ''This development is a step forward in the direction towards reinforcing the newly formed Northern cluster. It also echoes our group's commitment towards developing this region as vibrant as the existing Karnataka and Eastern clusters. We believe our recent ventures in NCR will help us target this key geography more efficiently while accelerating our trajectory to become a true Pan-India healthcare service provider.''

Shares of the company declined Rs 1.55, or 0.11%, to trade at Rs 316.80. The total volume of shares traded was 766 at the BSE (2.59 p.m., Friday).

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Reliance Comm plunges after reporting loss in Q4 - 29-May-2017 11:05
Reliance Comm swings to loss in Jan-Mar quarter - 29-May-2017 11:01
Tech Mahindra tumbles after poor Q4 results - 29-May-2017 10:56
Tech Mahindra quarterly net drops 33% - 29-May-2017 10:51
PSP Projects lists at 9% discount - 29-May-2017 10:22
Bank of Baroda to raise Rs 90 bn through equity dilution - 29-May-2017 09:58
JSPL completes 6 MTPA integrated steel plant at Angul - 29-May-2017 09:46
Zydus Cadila gets final approval for Acamprosate Calcium Tablets - 29-May-2017 09:41
Glenmark receives final approval for generic version of Bystolic Tablets - 29-May-2017 09:22
Strides Shasun completes USFDA inspection at Bangalore facility with 3 observations - 29-May-2017 09:18
Ashok Leyland turns to profit in Jan-Mar quarter - 26-May-2017 17:40
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer